Los Angeles Capital Management
TMDX icon

Los Angeles Capital Management’s Transmedics TMDX Stock Holding History

Los Angeles Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Sell
156
-4,434
-97% -$375K ﹤0.01% 1953
2026
Q1 		$456K Sell
4,590
-20,970
-82% -$2.74M ﹤0.01% 901
2025
Q4 		$3.47M Sell
25,560
-372
-1% -$46.7K 0.01% 348
2025
Q3 		$2.91M Buy
25,932
+13,933
+116% +$1.63M 0.01% 416
2025
Q2 		$1.61M Buy
+11,999
New +$1.32M 0.01% 501
2024
Q4 		– Sell
-10,866
Closed -$1.71M – 1242
2024
Q3 		$1.71M Buy
10,866
+1,559
+17% +$240K 0.01% 496
2024
Q2 		$1.4M Buy
9,307
+1,551
+20% +$186K 0.01% 543
2024
Q1 		$573K Sell
7,756
-2,588
-25% -$213K ﹤0.01% 833
2023
Q4 		$816K Buy
10,344
+2,219
+27% +$134K ﹤0.01% 734
2023
Q3 		$445K Sell
8,125
-235
-3% -$16.9K ﹤0.01% 847
2023
Q2 		$702K Buy
+8,360
New +$640K ﹤0.01% 750

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Los Angeles Capital Management's TMDX Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Transmedics (TMDX) stake by 97% in Q2 2026, selling an estimated $375K and leaving 156 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1953.

Los Angeles Capital Management first reported a position in TMDX in Q2 2023 and has held it in 11 quarters since. The position peaked at $3.47M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Los Angeles Capital Management held 156 shares of Transmedics worth $10.4K as of Q2 2026.
  • Los Angeles Capital Management sold 4,434 Transmedics shares in Q2 2026, an estimated $375K.
  • Transmedics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1953 holding.
  • Los Angeles Capital Management first reported a position in Transmedics in Q2 2023 and has held it in 11 quarters since.
  • Los Angeles Capital Management's Transmedics position peaked at $3.47M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.